These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2635640)

  • 1. [Early adjuvant intraportal chemotherapy with 5-fluorouracil after hepatic resection of colorectal metastasis: a preliminary clinical and pharmacokinetic study].
    Seitz JF; Aubert C; Giovannini M; Delpero JR; Houvenaeghel G; Guerinel G; Carcassonne Y
    Bull Cancer; 1989; 76(10):1127-32. PubMed ID: 2635640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis.
    Tsujitani S; Watanabe A; Kakeji Y; Maehara Y; Tomoda H; Furusawa M; Sugimachi K
    Eur J Surg Oncol; 1991 Oct; 17(5):526-9. PubMed ID: 1936301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early adjuvant intraportal chemotherapy after hepatectomy for metastases of colorectal origin].
    Lasser P; Elias D; Rougier P
    J Chir (Paris); 1986 May; 123(5):318-9. PubMed ID: 3745316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of continuous intra-arterial infusion chemotherapy after hepatic resection of liver metastases in colorectal cancer].
    Takahashi K; Mori T; Takahashi T
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1935-9. PubMed ID: 1877835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-arterial chemotherapy with 5-FU (weekly high dose 5-FU HAI) for the prevention of tumor recurrence in residual liver after hepatic resection of metastasis from colorectal cancer].
    Tsuji Y; Katsuki Y; Yasuda T; Nishimura A; Shinohara M
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1520-3. PubMed ID: 8373210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The preventive effect of weekly high-dose 5-FU infusion (WHF) after resection of hepatic metastasis from colorectal cancer].
    Tsuji Y; Nishimura A; Katsuki Y; Yasuda T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1454-6. PubMed ID: 8854778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraportal infusion of 5-FU and lipiodol-aclarubicin after hepatic resection for colorectal liver metastasis].
    Ambiru S; Miyazaki M; Ito H; Kaiho T; Ando K; Hayashi S; Nakajima N
    Nihon Geka Gakkai Zasshi; 1995 Mar; 96(3):145-52. PubMed ID: 7731455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
    Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Portal vein infusion therapy of the prevention of liver metastasis from colorectal carcinomas].
    Okubo Y; Maruyama H; Imajo M; Iwama T; Yaegashi K; Mishima Y
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3028-31. PubMed ID: 2782906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of prophylactic hepatic arterial infusion chemotherapy after hepatectomy for metastases from colorectal cancer].
    Tono T; Kikkawa N; Tamaki Y; Yagyu T; Mishima H; Morita T; Takemasa I; Fukuda K; Shin E; Kobayashi K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1500-3. PubMed ID: 7574743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is portal infusion chemotherapy uneffective for hepatic recurrence after resection for colorectal cancer?].
    Yamamura T; Akaishi O; Tsukikawa S; Yamaguchi S; Yabe K
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1756-8. PubMed ID: 10560388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three cases in which CR was obtained in residual metastatic lesions by intrahepatic arterial infusion after resection of hepatic metastases from colorectal carcinoma].
    Tsuji Y; Hamada H; Kimura J; Matsumoto S; Fujimori A; Hasegawa K; Yamagami H; Katsuki Y; Ohira S
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1966-9. PubMed ID: 11086455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases--a pilot study.
    Elias D; Lasser P; Rougier P; Nitenberg G; Théodore C; Lumbroso J
    Eur J Surg Oncol; 1987 Jun; 13(3):247-50. PubMed ID: 3595888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of prophylactic intra-hepatic-arterial infusion chemotherapy after resection of hepatic metastases from colorectal primaries].
    Tono T; Tamaki Y; Yagyu T; Mishima H; Nakagawa H; Cho G; Shin E; Kobayashi K; Takatsuka Y; Kikkawa N
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2158-61. PubMed ID: 7944428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Takanishi K; Matsumoto J; Minami T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of postoperative recurrence after hepatic resection for metastatic colorectal cancer by adjuvant locoregional chemotherapy].
    Endo Y; Tani T; Kawaguchi A; Eguchi Y; Sano H; Kurumi Y; Hanasawa K; Ishibashi H; Terata N; Shibata J
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1535-7. PubMed ID: 8396906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventive chemotherapy for residual liver after resection of hepatic metastasis from colorectal cancer].
    Tsuji Y; Nishimura A; Katsuki Y; Yasuda T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1493-6. PubMed ID: 7574741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases.
    Okuno K; Shigeoka H; Lee YS; Son E; Kayama H; Nakai T; Koh K; Yasutomi M
    Hepatogastroenterology; 1996; 43(9):688-91. PubMed ID: 8799416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.